Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (9)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Ledda-Columbano, G.M.
Right arrow Articles by Columbano, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ledda-Columbano, G.M.
Right arrow Articles by Columbano, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis, Vol. 20, No. 12, 2299-2304, December 1999
© 1999 Oxford University Press


Carcinogenesis

Cell proliferation induced by 3,3',5-triiodo-L-thyronine is associated with a reduction in the number of preneoplastic hepatic lesions

G.M. Ledda-Columbano2, A. Perra, R. Piga, M. Pibiri, R. Loi, H. Shinozuka1 and A. Columbano

Dipartimento di Tossicologia, Sezione di Oncologia e Patologia Molecolare, Via Porcell 4, 09124 Cagliari, Italy and
1 Department of Pathology, Pittsburgh, PA, USA

Previous studies have suggested that liver cell proliferation is fundamental for the growth of carcinogen-initiated cells. To gain further information on the association between cell proliferation and hepatocarcinogenesis, we have examined the effect of the hormone 3,3',5-triiodo-L-thyronine (T3), a strong liver mitogen, on the growth of diethylnitrosamine (DENA)-induced hepatic lesions positive for the placental form of glutathione S-transferase (GSTP). Two weeks after a single initiating dose of DENA (150 mg/kg), cycles of liver cell proliferation were induced in male Fischer rats by feeding a T3-supplemented diet (4 mg/kg) 1 week/month for 7 months. Rats were killed at the end of the seventh cycle or 1 month later. Results indicate that, in spite of an increased labelling index, a 70% reduction in the number/cm2 of GSTP-positive minifoci occurred in T3-treated rats. A decrease in the number of GSTP-positive foci was also observed in T3-treated rats killed 1 month after the last exposure to the hormone (40, versus 67 foci/cm2 in controls), indicating that the reduction was not due to an inhibitory effect on GSTP exerted by the concomitant presence of T3. In a second series of experiments where DENA-treated rats were fed T3 for 1 week and then subjected to the resistant hepatocyte (RH) model, it was found that T3 treatment prior to promotion resulted in a decrease in the number of GSTP-positive foci (16 GSTP+ foci/cm2 in T3-fed animals versus 45 in the control group). The results indicate that cell proliferation associated with T3 treatment: (i) reduces the number of carcinogen-induced GSTP-positive lesions; (ii) does not exert any differential effect on the growth of the remaining foci; (iii) inhibits the capacity of putative DENA-initiated cells to be promoted by the RH model. Data suggest that cell proliferation may not necessarily represent a stimulus for the growth of putative preneoplastic lesions.

Abbreviations: 2-AAF, 2-acetylaminofluorene; BrdU, bromodeoxyuridine; DENA, diethylnitrosamine; GSTP, glutathione S-transferase placental form; LI, labelling index; PH, partial hepatectomy; PP, peroxisome proliferators; PPAR, peroxisome proliferator-activated receptor; RH, resistant hepatocyte; RXR, retinoic acid receptor; T3, 3,3',5-triiodo-L-thyronine; TR, T3 receptor.

2 To whom correspondence should be addressed Email: gmledda{at}vaxca1.unica.it


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
EndocrinologyHome page
A. Columbano, M. Pibiri, M. Deidda, C. Cossu, T. S. Scanlan, G. Chiellini, S. Muntoni, and G. M. Ledda-Columbano
The Thyroid Hormone Receptor-{beta} Agonist GC-1 Induces Cell Proliferation in Rat Liver and Pancreas
Endocrinology, July 1, 2006; 147(7): 3211 - 3218.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
Y. C. Ou, R. B. Conolly, R. S. Thomas, D. L. Gustafson, M. E. Long, I. D. Dobrev, L. S. Chubb, Y. Xu, S. A. Lapidot, M. E. Andersen, et al.
Stochastic Simulation of Hepatic Preneoplastic Foci Development for Four Chlorobenzene Congeners in a Medium-Term Bioassay
Toxicol. Sci., June 1, 2003; 73(2): 301 - 314.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
G. M. Ledda-Columbano, A. Perra, D. Concas, C. Cossu, F. Molotzu, C. Sartori, H. Shinozuka, and A. Columbano
Different Effects of the Liver Mitogens Triiodo-Thyronine and Ciprofibrate on the Development of Rat Hepatocellular Carcinoma
Toxicol Pathol, January 1, 2003; 31(1): 113 - 120.
[Abstract] [PDF]


Home page
Toxicol PatholHome page
P. Bannasch, T. Haertel, and Qin Su
Significance of Hepatic Preneoplasia in Risk Identification and Early Detection of Neoplasia
Toxicol Pathol, January 1, 2003; 31(1): 134 - 139.
[Abstract] [PDF]


Home page
CarcinogenesisHome page
M. Evert, T. Ott, A. Temme, K. Willecke, and F. Dombrowski
Morphology and morphometric investigation of hepatocellular preneoplastic lesions and neoplasms in connexin32-deficient mice
Carcinogenesis, May 1, 2002; 23(5): 697 - 703.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.